Editorial: on the road towards treatment of gastroparesis-accelerating, but do we get closer? Authors' reply.

Kuo, Braden; Barnes, Chris N; Nguyen, Deanna D; Shaywitz, David; Grimaldi, Maria; Renzulli, Cecilia; Canafax, Daniel; Parkman, Henry P

Kuo, Braden; Barnes, Chris N; Nguyen, Deanna D; Shaywitz, David; Grimaldi, Maria; Renzulli, Cecilia; Canafax, Daniel; Parkman, Henry P.

Affiliation

Kuo B; Massachusetts General Hospital, Boston, MA, USA.
Barnes CN; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Nguyen DD; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Shaywitz D; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Grimaldi M; Alfasigma S.p.A., Bologna, Italy.
Renzulli C; Alfasigma S.p.A., Bologna, Italy.
Canafax D; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Parkman HP; Temple University School of Medicine, Philadelphia, PA, USA.

Aliment Pharmacol Ther ; 54(2): 185-186, 2021 07.

Article in En | MEDLINE | ID: mdl-34170530

Subject(s)

Gastroparesis; Gastroparesis/therapy; Humans

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroparesis Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google